Use of the S3 guidelines for early detection of prostate cancer in urological practices

被引:3
|
作者
Tiedje, D. [1 ]
Quer, O. [2 ]
Breil, B. [2 ]
Schrader, A. J. [1 ]
Bothe, C. [1 ]
Kruse, K. [1 ]
Boegemann, M. [1 ]
Donner-Banzhoff, N. [3 ]
Semjonow, A. [1 ]
机构
[1] Univ Klinikum Munster, Klin Urol & Kinderurol, Prostatazentrum, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany
[2] Hsch Niederrhein, Fachbereich Gesundheitswesen, Krefeld, Germany
[3] Philipps Univ Marburg, Abt Allgemeinmed Pravent & Rehabil Med, Marburg, Germany
来源
UROLOGE | 2017年 / 56卷 / 07期
关键词
Adherence; Focus groups; Interview; Prostate biopsy; Prostate cancer;
D O I
10.1007/s00120-017-0352-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The German S3 guideline on prostate cancer gives recommendations on early detection of prostate cancer. In this study we analyzed the adherence of urologists in private practice from the administrative district of Munster, Germany to this guideline. Data were collected through a semistructured survey of 22 urologists based on the COREQ checklist (Consolidated criteria for reporting qualitative research) in four focus groups consisting of five or six urologists in private practice. We developed 23 questions relating to 12 recommendations of the paragraphs of the S3 guidelines dealing with early detection of prostate cancer and prostate biopsy. The recommendations of the guideline are subdivided in nine "strong", one "optional recommendation" and two "statements". The adherence to the guideline was investigated by using frequency and qualitative content analysis (Mayring) based on a mixed methods design. The urologists follow six of the nine "strong recommendations" of the guideline and deviate from three. Reasons for deviations from "strong recommendations" are the following: information about advantages and disadvantages of early detection for prostate cancer, recommendation of a prostate biopsy in case of PSA level ae<yen>4 ng/ml, and indication for repeat biopsy. Most of the "strong recommendations" are followed by the interviewed urologists of the administrative district of Munster. Contextually relevant deviations from "strong recommendations" are justified, e. g., the only limited transferability of the PSA threshold of 4 ng/ml derived from population-based studies of asymptomatic men to men presenting in a urologist's office.
引用
收藏
页码:910 / 916
页数:7
相关论文
共 50 条
  • [1] Anwendung der S3-Leitlinie zur Prostatakrebsfrüherkennung in urologischen PraxenUse of the S3 guidelines for early detection of prostate cancer in urological practices
    D. Tiedje
    O. Quer
    B. Breil
    A. J. Schrader
    C. Bothe
    K. Kruse
    M. Bögemann
    N. Donner-Banzhoff
    A. Semjonow
    [J]. Der Urologe, 2017, 56 : 910 - 916
  • [2] S3 guidelines for diagnostics and therapy of prostate cancer
    Wirth, M. P.
    Froehner, M.
    [J]. ONKOLOGE, 2012, 18 (04): : 355 - 361
  • [3] Zusammenfassung – S3‑Leitlinien PankreaskarzinomSynopsis—S3 guidelines pancreatic cancer
    Christiane J. Bruns
    [J]. Der Chirurg, 2022, 93 (5): : 427 - 428
  • [4] S3 Guideline Prevention and Early detection of Skin Cancer
    Follmann, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 36 - 36
  • [5] NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection
    Carroll, Peter H.
    Mohler, James L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 620 - 623
  • [6] What's new in the S3 guidelines for breast cancer
    Lebeau, A.
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 263 - 263
  • [7] New S3 guidelines on exocrine pancreatic cancer
    Tannapfel, A.
    [J]. PATHOLOGE, 2012, 33 : 266 - 268
  • [8] S3 guidelines on breast cancer: locoregional treatment
    Fehm T.
    Wöckel A.
    Kühn T.
    [J]. Der Gynäkologe, 2018, 51 (7): : 526 - 530
  • [9] S3 Guidelines on Anal Cancer - also as an App
    Mugele, Katrin
    [J]. COLOPROCTOLOGY, 2021, 43 (01) : 2 - 2
  • [10] Oncology S3 Guidelines for the Prevention of Skin Cancer
    不详
    [J]. AKTUELLE DERMATOLOGIE, 2014, 40 (05) : 166 - 166